JP2018520198A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018520198A5 JP2018520198A5 JP2018502683A JP2018502683A JP2018520198A5 JP 2018520198 A5 JP2018520198 A5 JP 2018520198A5 JP 2018502683 A JP2018502683 A JP 2018502683A JP 2018502683 A JP2018502683 A JP 2018502683A JP 2018520198 A5 JP2018520198 A5 JP 2018520198A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- amount
- sweat
- compared
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 47
- 238000004519 manufacturing process Methods 0.000 claims 12
- 210000004243 sweat Anatomy 0.000 claims 12
- 150000001875 compounds Chemical class 0.000 claims 10
- 208000008454 Hyperhidrosis Diseases 0.000 claims 9
- 230000037315 hyperhidrosis Effects 0.000 claims 9
- VPNYRYCIDCJBOM-UHFFFAOYSA-M Glycopyrronium bromide Chemical compound [Br-].C1[N+](C)(C)CCC1OC(=O)C(O)(C=1C=CC=CC=1)C1CCCC1 VPNYRYCIDCJBOM-UHFFFAOYSA-M 0.000 claims 8
- FIAFMTCUJCWADZ-UHFFFAOYSA-M [1-(2-ethoxy-2-oxoethyl)-1-methylpyrrolidin-1-ium-3-yl] 2-cyclopentyl-2-hydroxy-2-phenylacetate;bromide Chemical group [Br-].C1[N+](CC(=O)OCC)(C)CCC1OC(=O)C(O)(C=1C=CC=CC=1)C1CCCC1 FIAFMTCUJCWADZ-UHFFFAOYSA-M 0.000 claims 8
- 229940015042 glycopyrrolate Drugs 0.000 claims 8
- 230000000699 topical effect Effects 0.000 claims 8
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 6
- 239000000546 pharmaceutical excipient Substances 0.000 claims 6
- 229940008099 dimethicone Drugs 0.000 claims 5
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims 5
- 239000004205 dimethyl polysiloxane Substances 0.000 claims 5
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 claims 4
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical group O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 claims 4
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 claims 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 4
- 239000000969 carrier Substances 0.000 claims 4
- 229940086555 cyclomethicone Drugs 0.000 claims 4
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 239000012062 aqueous buffer Substances 0.000 claims 2
- 239000003125 aqueous solvent Substances 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 229940031661 dimethicone 350 Drugs 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 229940051250 hexylene glycol Drugs 0.000 claims 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims 2
- 239000004615 ingredient Substances 0.000 claims 2
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical group C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 claims 2
- 238000002360 preparation method Methods 0.000 claims 2
- 238000005809 transesterification reaction Methods 0.000 claims 2
- FIAFMTCUJCWADZ-NRQRHMLOSA-M [1-(2-ethoxy-2-oxoethyl)-1-methylpyrrolidin-1-ium-3-yl] (2r)-2-cyclopentyl-2-hydroxy-2-phenylacetate;bromide Chemical compound [Br-].C1[N+](CC(=O)OCC)(C)CCC1OC(=O)[C@](O)(C=1C=CC=CC=1)C1CCCC1 FIAFMTCUJCWADZ-NRQRHMLOSA-M 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 229920001296 polysiloxane Polymers 0.000 claims 1
- 238000003860 storage Methods 0.000 claims 1
- 238000005303 weighing Methods 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019211360A JP6976594B2 (ja) | 2015-07-21 | 2019-11-22 | ソフト抗コリン類似体のための製剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14/805,114 US20150320722A1 (en) | 2014-03-13 | 2015-07-21 | Formulation for soft anticholinergic analogs |
| US14/805,114 | 2015-07-21 | ||
| PCT/US2016/043380 WO2017015485A1 (en) | 2015-07-21 | 2016-07-21 | Formulation for soft anticholinergic analogs |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019211360A Division JP6976594B2 (ja) | 2015-07-21 | 2019-11-22 | ソフト抗コリン類似体のための製剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018520198A JP2018520198A (ja) | 2018-07-26 |
| JP2018520198A5 true JP2018520198A5 (enExample) | 2019-08-29 |
| JP6647692B2 JP6647692B2 (ja) | 2020-02-14 |
Family
ID=57834721
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018502683A Active JP6647692B2 (ja) | 2015-07-21 | 2016-07-21 | ソフト抗コリン類似体のための製剤 |
| JP2019211360A Active JP6976594B2 (ja) | 2015-07-21 | 2019-11-22 | ソフト抗コリン類似体のための製剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019211360A Active JP6976594B2 (ja) | 2015-07-21 | 2019-11-22 | ソフト抗コリン類似体のための製剤 |
Country Status (16)
| Country | Link |
|---|---|
| US (4) | US20180228770A1 (enExample) |
| EP (1) | EP3325487B1 (enExample) |
| JP (2) | JP6647692B2 (enExample) |
| KR (3) | KR102762010B1 (enExample) |
| CN (4) | CN119033771A (enExample) |
| AU (1) | AU2016297601B2 (enExample) |
| CA (2) | CA3232529A1 (enExample) |
| ES (1) | ES2881998T3 (enExample) |
| HK (1) | HK1253236A1 (enExample) |
| HU (1) | HUE055663T2 (enExample) |
| MX (1) | MX386488B (enExample) |
| MY (1) | MY185814A (enExample) |
| PH (1) | PH12018500184A1 (enExample) |
| PL (1) | PL3325487T3 (enExample) |
| WO (1) | WO2017015485A1 (enExample) |
| ZA (1) | ZA201800878B (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2658897T3 (es) | 2011-08-24 | 2018-03-12 | Novan, Inc. | Macromoléculas de liberación de óxido nítrico ajustables que tienen múltiples estructuras donantes de óxido nítrico |
| US11813284B2 (en) | 2013-08-08 | 2023-11-14 | Novan, Inc. | Topical compositions and methods of using the same |
| US20150259283A1 (en) | 2014-03-13 | 2015-09-17 | Brickell Biotech, Inc. | Formulation for soft anticholinergic analogs |
| US10322082B2 (en) | 2014-07-11 | 2019-06-18 | Novan, Inc. | Topical antiviral compositions and methods of using the same |
| CN119033771A (zh) * | 2015-07-21 | 2024-11-29 | 博多尔实验仪器公司 | 软性抗胆碱能药类似物的制剂 |
| TWI767507B (zh) * | 2016-07-21 | 2022-06-11 | 美商波德實驗股份有限公司 | 軟性抗膽鹼類似物之製劑 |
| JP2022554264A (ja) * | 2019-11-05 | 2022-12-28 | ジャーニー メディカル コーポレーション | 医薬組成物の手掌又は足底投与のための方法 |
| SG10201912063PA (en) * | 2019-12-12 | 2021-07-29 | Nat Skin Centre Singapore Pte Ltd | A pharmaceutical formulation |
| WO2021177257A1 (ja) * | 2020-03-03 | 2021-09-10 | 科研製薬株式会社 | 原発性腋窩多汗症の治療方法、及びその医薬 |
| CA3174550A1 (en) * | 2020-03-03 | 2021-09-10 | Kaken Pharmaceutical Co., Ltd. | Medicament containing sofpironium bromide |
| FR3124081B1 (fr) * | 2021-06-21 | 2023-12-29 | Oreal | Composition cosmétique comprenant au moins une huile polaire, un polyol et au moins un actif hydrophile |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK149832C (da) * | 1981-07-17 | 1987-05-18 | Riemann Claus | Antiperspirantpraeparat bestaaende af to komponenter |
| DK483587D0 (da) | 1987-09-15 | 1987-09-15 | Riemann & Co Aps Claus | Antiperspirant praeparat |
| US5292530A (en) * | 1991-06-02 | 1994-03-08 | Helene Curtis, Inc. | Stable anhydrous topically-active composition and suspending agent therefor |
| US5232689A (en) * | 1990-12-21 | 1993-08-03 | Dow Corning Corporation | Translucent antiperspirant compositions |
| US5143719A (en) * | 1991-04-16 | 1992-09-01 | Chesebrough-Pond's Usa Co. | Anticalculus oral composition containing combinations of organophosphorus polycarboxylate cotelomers and inorganic polyphosphate salts |
| GB2280111B (en) | 1993-07-16 | 1997-05-07 | Union Camp Corp | Clear gel antiperpirant compositions |
| US6290991B1 (en) * | 1994-12-02 | 2001-09-18 | Quandrant Holdings Cambridge Limited | Solid dose delivery vehicle and methods of making same |
| US5895644A (en) | 1997-11-20 | 1999-04-20 | Colgate-Palmolive Company | Clear antiperspirant stick with dibenzylidene sorbitol and guar and process of making same |
| US6433003B1 (en) * | 1999-04-23 | 2002-08-13 | Arthur M. Bobrove | Method for treating hyperhidrosis in mammals |
| US6319491B1 (en) | 2000-04-11 | 2001-11-20 | Michael B. Whipple | Anti-sweat lotion |
| EP1438001A4 (en) * | 2001-09-26 | 2006-03-15 | Alison B Lukacsko | COMPOSITIONS AND METHODS FOR INHIBITING ECCRINS PERSPIRATION IN HUMANS |
| JP2003113392A (ja) | 2001-10-04 | 2003-04-18 | Kiyomitsu Kawasaki | 芳香・消臭組成物および該芳香・消臭組成物を含有する人体用芳香・消臭剤 |
| US8252316B2 (en) | 2002-05-03 | 2012-08-28 | Purepharm Inc. | Method of topically applying glycopyrrolate solution using absorbent pad to reduce sweating |
| BR0308051A (pt) | 2003-12-15 | 2005-09-06 | Natura Cosmeticos Sa | Composição base para preparação de formulações multifuncionais para o cuidado e proteção da pele e cabelo |
| AU2005265248A1 (en) * | 2004-06-23 | 2006-01-26 | Ortho-Mcneil Pharmaceutical, Inc. | Methods for measuring chloride channel conductivity |
| US7087560B2 (en) | 2004-10-25 | 2006-08-08 | Unilever Home & Personal Care Usa, A Division Of Conopco, Inc. | Personal care composition with salts of dihydroxypropyltri(C1-C3 alkyl) ammonium monosubstituted polyols |
| US20060088496A1 (en) | 2004-10-25 | 2006-04-27 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Personal care compositions with salts of hydroxypropyl trialkylammonium substituted mono-saccharide |
| GB0428418D0 (en) | 2004-12-24 | 2005-02-02 | Novartis Ag | Organic compounds |
| GB0428416D0 (en) | 2004-12-24 | 2005-02-02 | Novartis Ag | Organic compounds |
| WO2006069998A2 (de) * | 2004-12-27 | 2006-07-06 | Beiersdorf Ag | Glycopyrrolat in kosmetischen zubereitungen |
| JP2007058971A (ja) | 2005-08-24 | 2007-03-08 | Alpine Electronics Inc | 情報再生装置 |
| ATE529399T1 (de) | 2005-11-10 | 2011-11-15 | Nicholas S Bodor | Sanfte anticholinerge ester |
| ATE529400T1 (de) | 2005-11-10 | 2011-11-15 | Nicholas S Bodor | Weiche anticholinerge zwitterionen |
| US20080023423A1 (en) * | 2006-07-31 | 2008-01-31 | James Francis Duffy | Device for Holding and Displaying Vial-shaped Beverage Containers |
| JP5371235B2 (ja) | 2006-12-06 | 2013-12-18 | ロート製薬株式会社 | 皮膚外用剤 |
| US10265265B2 (en) | 2007-03-15 | 2019-04-23 | Drug Delivery Solutions Limited | Topical composition |
| ES2671874T3 (es) * | 2007-10-18 | 2018-06-11 | Rose U, Llc | Formulaciones tópicas de glicopirrolato |
| CN103784401A (zh) * | 2012-10-29 | 2014-05-14 | 北京市丰硕维康技术开发有限责任公司 | 一种治疗呼吸道疾病的溶液型定量吸入气雾剂及制备方法 |
| WO2014144075A1 (en) | 2013-03-15 | 2014-09-18 | Bodor Laboratories, Inc. | Anticholinergic glycopyrrolate esters for the treatment of hyperhidrosis |
| JP2016525569A (ja) * | 2013-07-30 | 2016-08-25 | グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ | 発汗過多の治療のための局所用組成物およびその使用方法 |
| JP2017507959A (ja) | 2014-03-13 | 2017-03-23 | ボドール ラボラトリーズ， インコーポレイテッド | 選択された抗コリン作動性両性イオンの使用 |
| US20150259283A1 (en) | 2014-03-13 | 2015-09-17 | Brickell Biotech, Inc. | Formulation for soft anticholinergic analogs |
| CN119033771A (zh) | 2015-07-21 | 2024-11-29 | 博多尔实验仪器公司 | 软性抗胆碱能药类似物的制剂 |
| TWI767507B (zh) | 2016-07-21 | 2022-06-11 | 美商波德實驗股份有限公司 | 軟性抗膽鹼類似物之製劑 |
-
2016
- 2016-07-21 CN CN202411185418.4A patent/CN119033771A/zh active Pending
- 2016-07-21 AU AU2016297601A patent/AU2016297601B2/en active Active
- 2016-07-21 MX MX2018000918A patent/MX386488B/es unknown
- 2016-07-21 HK HK18112521.3A patent/HK1253236A1/zh unknown
- 2016-07-21 CN CN202411185417.XA patent/CN119033770A/zh active Pending
- 2016-07-21 CA CA3232529A patent/CA3232529A1/en active Pending
- 2016-07-21 CA CA2993602A patent/CA2993602C/en active Active
- 2016-07-21 JP JP2018502683A patent/JP6647692B2/ja active Active
- 2016-07-21 PL PL16828553T patent/PL3325487T3/pl unknown
- 2016-07-21 MY MYPI2018700255A patent/MY185814A/en unknown
- 2016-07-21 WO PCT/US2016/043380 patent/WO2017015485A1/en not_active Ceased
- 2016-07-21 KR KR1020237035926A patent/KR102762010B1/ko active Active
- 2016-07-21 CN CN201680054285.4A patent/CN108137612A/zh active Pending
- 2016-07-21 ES ES16828553T patent/ES2881998T3/es active Active
- 2016-07-21 EP EP16828553.4A patent/EP3325487B1/en active Active
- 2016-07-21 US US15/746,358 patent/US20180228770A1/en not_active Abandoned
- 2016-07-21 KR KR1020187004898A patent/KR20180030893A/ko not_active Ceased
- 2016-07-21 CN CN202411185422.0A patent/CN119033772A/zh active Pending
- 2016-07-21 HU HUE16828553A patent/HUE055663T2/hu unknown
- 2016-07-21 KR KR1020257002804A patent/KR20250024093A/ko active Pending
-
2018
- 2018-01-24 PH PH12018500184A patent/PH12018500184A1/en unknown
- 2018-02-09 ZA ZA2018/00878A patent/ZA201800878B/en unknown
-
2019
- 2019-11-22 JP JP2019211360A patent/JP6976594B2/ja active Active
- 2019-12-05 US US16/704,736 patent/US10952990B2/en active Active
-
2020
- 2020-11-30 US US17/107,942 patent/US11026919B2/en active Active
-
2021
- 2021-03-22 US US17/208,676 patent/US12357609B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018520198A5 (enExample) | ||
| JP2017214429A5 (enExample) | ||
| JP2019189650A5 (enExample) | ||
| JP2017507970A5 (enExample) | ||
| CN106456603B (zh) | 软性抗胆碱能药类似物的制剂 | |
| JP2016517431A5 (enExample) | ||
| KR102762010B1 (ko) | 연성 항콜린제 유사체를 위한 제제 | |
| FI3487475T3 (fi) | Formulaatio pehmeille antikolinergisille analogeille | |
| JP2010537988A5 (enExample) | ||
| US20180235984A1 (en) | Tetracycline management of egfr inhibitor associated dermatoses | |
| DK2525796T3 (en) | An aqueous solution comprising 3-quinuclidinoner for the treatment of hyperproliferative disease, autoimmune disease and heart disease | |
| JP2020520963A (ja) | 抑うつ障害の処置 | |
| TW201912156A (zh) | 組成物在製備治療睡眠障礙的藥劑的用途 | |
| WO2016024369A1 (ja) | がん治療用医薬組成物 | |
| CN103189041B (zh) | 手指甲或脚趾甲生长促进用组合物 | |
| KR102627092B1 (ko) | 수중유 에멀젼 | |
| US20090281197A1 (en) | Acetic Acid/Thymol Compositions and Their Use in the Treatment of Onychomycosis | |
| JP2017088558A (ja) | セラミド合成促進剤 | |
| KR101875463B1 (ko) | 다한증 치료제 조성물 및 그 제조방법 | |
| BG1841U1 (bg) | Парентерална лекарствена форма | |
| HK40119997A (zh) | 软性抗胆碱能药类似物的制剂 | |
| HK40119619A (zh) | 软性抗胆碱能药类似物的制剂 | |
| HK40119620A (zh) | 软性抗胆碱能药类似物的制剂 | |
| Base | CUTIS Do Not Copy | |
| HK1233922B (zh) | 软性抗胆碱能药类似物的制剂 |